Healthy Participant

3
Pipeline Programs
2
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 2 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
2 programs
2
PF-07220060Phase 11 trial
PF-07321332/ritonavirPhase 1Small Molecule5 trials
Active Trials
NCT07130097Completed35Est. Nov 2025
NCT05263921Completed12Est. May 2022
NCT05339334Completed14Est. Apr 2022
+3 more trials
Denali Therapeutics
Denali TherapeuticsCA - South SF
1 program
1
DNL919Phase 1

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerPF-07220060
PfizerPF-07321332/ritonavir
PfizerPF-07321332/ritonavir
PfizerPF-07321332/ritonavir
PfizerPF-07321332/ritonavir
PfizerPF-07321332/ritonavir
PfizerPF-07321332/ritonavir

Clinical Trials (7)

Total enrollment: 109 patients across 7 trials

A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants

Start: Aug 2025Est. completion: Nov 202535 patients
Phase 1Completed
NCT05263921PfizerPF-07321332/ritonavir

Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants

Start: Mar 2022Est. completion: May 202212 patients
Phase 1Completed
NCT05339334PfizerPF-07321332/ritonavir

A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Start: Mar 2022Est. completion: Apr 202214 patients
Phase 1Completed
NCT05263895PfizerPF-07321332/ritonavir

Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation

Start: Mar 2022Est. completion: May 202212 patients
Phase 1Completed
NCT05129475PfizerPF-07321332/ritonavir

Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants

Start: Nov 2021Est. completion: Jan 202212 patients
Phase 1Completed
NCT05064800PfizerPF-07321332/ritonavir

PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants

Start: Sep 2021Est. completion: Dec 202124 patients
Phase 1Completed
NCT04962230PfizerPF-07321332/ritonavir

Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir

Start: Jul 2021Est. completion: Oct 2021
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space